# Patient Care Plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Lou Gehrig (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET018-SYN-TD
- Date: 1939-05-04
- Fictional facility: St. Posthumous Health Center
- Fictional author: Gavin Hollister, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## What we are working on

- Over about a year he has lost strength and coordination, fumbles with buttons and a bat, trips on curbs, and fell on the ice in the winter, and he wants to know why **S**
- He has stopped playing and wants plain answers, delivered to him first **S**
- He wants to stay useful and to keep working in some form **S**

## Your goals

- A clear diagnosis, with mimics excluded, within four weeks. Target: 1939-05-18. Recorded outcome: Diagnosis made at two weeks on EMG, MRI and blood tests. **S**
- No falls, using an ankle-foot orthosis, a cane, and a safer home. Target: 1939-10-19. Recorded outcome: One fall with an ankle sprain in July, on a day the orthosis was not worn; no falls since it has been worn for all walking outdoors. **S**
- Weight held within 5% of the weight at diagnosis. Target: 1939-10-19. Recorded outcome: 89.2 kg at diagnosis and 86.6 kg at five months (2.9% lower). **S**
- Breathing tracked every visit, with noninvasive ventilation started as soon as criteria are met. Target: 1939-10-19. Recorded outcome: FVC 72% and no symptoms at five months; overnight oximetry ordered. **S**
- Goals of care, a health care agent, and his wishes about ventilation and feeding recorded early and revisited. Target: 1939-09-21. Recorded outcome: Agent named and wishes recorded at the preventive visit. **S**
- Working in a role that suits him, with accommodations. Target: 1939-10-19. Recorded outcome: Started a desk role in public service with accommodations. **S**

## What we agreed to do

- Evaluation of progressive weakness with mixed upper and lower motor neuron signs: blood count, metabolic panel with calcium, creatine kinase, vitamin B12, TSH, A1c, serum protein electrophoresis with immunofixation, and an HIV test; MRI of the brain and cervical spine; seated spirometry. Guideline: Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review) (2009); A proposal for new diagnostic criteria for ALS (Gold Coast criteria) (2020); El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis (2000) **S**
- Neuromuscular neurology consultation with EMG and nerve conduction studies for progressive weakness with mixed upper and lower motor neuron signs. Guideline: Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review) (2009); A proposal for new diagnostic criteria for ALS (Gold Coast criteria) (2020) **S**
- Safety while the evaluation proceeds: no competitive play or heavy lifting, a physical therapy assessment of balance and gait, home fall precautions (night lights, rails, no loose rugs), and a same-day call for any trouble swallowing or breathing; results given to him first, in person. Guideline: Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review) (2009) **S**
- Riluzole 50 mg twice daily, with ALT monthly for the first 3 months and then every 3 months, and a blood count with any fever; genetic testing with genetic counseling for ALS-associated genes, with tofersen only if an SOD1 variant is found; edaravone discussed as an option with modest evidence in a selected group. Guideline: Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review) (2009); Evidence-based consensus guidelines for ALS genetic testing and counseling (2023); Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS (2022) **S**
- Multidisciplinary ALS clinic every 2 to 3 months (neurology, nursing, physical, occupational and speech therapy, nutrition, respiratory therapy, social work and mental health): ALSFRS-R, seated forced vital capacity and maximal inspiratory pressure, and weight at every visit; cognitive and behavioral screening; PHQ-9. Guideline: Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review) (2009); The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function (1999) **S**
- Respiratory plan: forced vital capacity and maximal inspiratory pressure every visit, supine capacity and overnight oximetry when values fall or symptoms appear; noninvasive ventilation when forced vital capacity is below 50% of predicted, maximal inspiratory pressure is weaker than -60 cmH2O, overnight oximetry shows desaturation, or orthopnea or morning headaches appear; influenza and COVID-19 vaccines. Guideline: Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review) (2009); Adult Immunization Schedule by Medical Condition and Other Indication (2026) **S**
- Nutrition, speech, swallowing and mobility: a high-calorie diet to keep weight stable, with gastrostomy discussed early, while forced vital capacity is above 50%; speech and swallowing assessments every visit and voice banking; a left ankle-foot orthosis, a cane, and an early power wheelchair evaluation because of lead times; home and car adaptations. Guideline: Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review) (2009); Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review) (2009) **S**
- Work and planning: workplace accommodations for a desk role (accessible office, flexible hours, rest breaks, voice-recognition software, parking), information on disability benefits, social work support, and early advance care planning, revisited at each change. Guideline: Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review) (2009) **S**

## Follow-up

- 1939-05-04: New patient with progressive weakness and loss of coordination: evaluation for a motor neuron disorder and its mimics, safety, and how he wants to receive results **S**
- 1939-05-18: Neuromuscular neurology consultation with EMG and nerve conduction studies; results of MRI and blood tests; diagnosis and start of treatment **S**
- 1939-06-29: Six weeks after diagnosis: riluzole safety, genetic test result, multidisciplinary ALS clinic, mobility, mood, and his decision about work **S**
- 1939-08-24: Three months after diagnosis: ALSFRS-R, breathing, weight, speech, mobility equipment, and work accommodations **S**
- 1939-09-21: Periodic adult preventive visit **S**
- 1939-10-19: Five months after diagnosis: breathing tests and noninvasive ventilation planning, nutrition and gastrostomy discussion, and his new desk work **S**

This teaching document does not replace care from a qualified clinician.
